← All trials
NCT04683224
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2021
- Primary completion
- Mar 22, 2023
- Completion date
- Mar 22, 2023
- First posted
- Dec 24, 2020
- Last posted
- Dec 24, 2020
- Enrollment
- 7320
- Arms / groups
- 8 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vaxxinity, Inc.Lead sponsor
- University of California, San FranciscoStudy chair
- Diagnósticos da América S/A (DASA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.